Updated initial conversion table based on clinical trials in adults showing significantly improved mealtime glycemic ...

This transcript has been edited for clarity. Jay H. Shubrook, DO: Hi. I'm Jay Shubrook, a professor of primary care at Touro University California in the College of Osteopathic Medicine and a ...

New Afrezza prescribing information outlines higher starting dose conversions for patients transitioning from mealtime ...

Stability in the thermal, chemical, and mechanical domains are critical for proper development and delivery of therapeutic proteins. Proteins are frequently exposed to stress throughout purification, ...

Most of the insulinmedication that people use today is made from bacteria that have been genetically modified to produce insulin that is identical to the kind made in the human pancreas, according to ...

Scientists inch closer to an autologous diabetes cell therapy that dodges the challenge of immune rejection, creating insulin-producing cells from the lining of the gut. As of 2025, an estimated 9.5 ...

A century ago, type 1 diabetes was a death sentence. Children diagnosed rarely survived more than a year or two, wasting away as their bodies starved despite food. Then, in 1921, in a modest lab in ...

So-called 'smart' insulin took a step nearer to becoming a reality with a new study from Denmark, the United Kingdom, and the Czech Republic. Researchers reported in Nature that animal tests with an ...

In a proof of concept that may reshape the treatment landscape for insulin-dependent diabetes, scientists have demonstrated that human stomach cells can be reprogrammed to secrete insulin—potentially ...

Novo Nordisk (NVO) reportedly plans to phase out production of its human insulin pens while it ramps up production of other injected diabetes medications such as Ozempic. The Danish drugmaker plans to ...